Searching for non-RET molecular alterations in medullary thyroid carcinoma: Expression analysis by mRNA differential display

World Journal of Surgery

Volumn 29, Issue 4, 2005, Pages 472-482

  Musholt, Thomas J ^a   Hanack, Julia ^b   Brehm, Christoph ^b   Von Wasielewski, Reinhard ^b   Musholt, Petra B ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; ELECTROPHORESIS; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; HUMAN; MALE; ONCOGENE; PATHOGENESIS; PROTEIN ANALYSIS; SOMATIC CELL; THYROID MEDULLARY CARCINOMA; UPREGULATION; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GENETICS; MEDULLARY CARCINOMA; METABOLISM; MIDDLE AGED; SIGNAL TRANSDUCTION; THYROID TUMOR;

ANXA2 PROTEIN, HUMAN; COPPER ZINC SUPEROXIDE DISMUTASE; DNA BINDING PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN GAMMA SUBUNIT; LIPOCORTIN 2; MUCIN; MUSCLE PROTEIN; ONCOPROTEIN; PEPTIDE; PROTEIN RET; PROTEIN TYROSINE KINASE; RAB PROTEIN; RAB11 PROTEIN; RET PROTEIN, HUMAN; SUPEROXIDE DISMUTASE; TFF3 PROTEIN, HUMAN;

ADULT; AGED; ANNEXIN A2; CARCINOMA, MEDULLARY; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION PROFILING; GTP-BINDING PROTEIN GAMMA SUBUNITS; HUMANS; MALE; MIDDLE AGED; MUCINS; MUSCLE PROTEINS; ONCOGENE PROTEINS; PEPTIDES; PROTO-ONCOGENE PROTEINS C-RET; RAB GTP-BINDING PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE; THYROID NEOPLASMS; TRANSCRIPTION, GENETIC;

EID: 23444437050     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-004-7748-y     Document Type: Article

References (32)

1. M Lindahl D Poteryaev L Yu 2000 Human GFR {alpha} 4 is the receptor for persephin, and is predominantly expressed in normal and malignant thyroid medullary cells J. Biol. Chem. 14 14
2. K Kurokawa K Kawai M Hashimoto 2003 Cell sigpalling and gene expression mediated RET tyrosine kinase J. Intern. Med. 253 627 633
3. M Santoro RM Melillo F Carlomagno 2002 Molecular mechanisms of RET activation in human cancer Ann. N. Y. Acad. Sci. 963 116 121
4. H Murakami Y Yamamura Y Shimono 2000 Role of Dok1 in cell signaling mediated by RET tyrosine kinase J. Biol. Chem. 277 32781 32790
5. O Gimm J Ukkat BE Niederle 2004 Timing and extent of surgery in patients with FMTC/MEN2A-related RET mutation not affecting codon 634 World J Surg 28 1312 1316
6. J Zedenius C Larsson U Bergholm 1995 Mutations of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomas J. Clin. Endocrinol. Metab. 80 3088 3090
7. DJ Marsh DL Learoyd SD Andrew 1996 Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma Clin. Endocrinol. (Oxf). 44 249 257
8. BA Ponder D Smith 1996 The MEN II syndromes and the role of the ret proto-oncogene Adv. Cancer Res 70 179 222
9. C Eng LM Mulligan DP Smith 1995 Mutation of the RET protooncogene in sporadic medullary thyroid carcinoma Genes, Chromosomes Cancer 2 209 212
10. TJ Musholt C Brehm J Hanack 2004 Identification of differentially expressed genes in papillary thyroid carcinoma with and without rearrangements of the tyrosine kinase receptors RET and/or NTRK1 Br. J. Surg.. (in press)
11. TJ Musholt PJ Goodfellow GF Scheumann 1997 Differential display in primary and metastatic medullary thyroid carcinoma J. Surg. Res 69 94 100
12. KW Schmid R Fischer-Colbrie C Hagn 1987 Chromogranin A and B and secretogranm II in medullary carcinomas of the thyroid Am. L. Surg. Pathol. 11 551 556
13. S Jindrichova R Kodet L Krskova 2003 The newly detected mutations in the RET proto-oncogene in exon 16 as a cause of sporadic medullary thyroid carcinoma J. Mol. Med. 81 819 823
14. AN Cranston BA Ponder 2003 Modulation of medullary thyroid carcinoma penetrance suggests the presence of modifier genes in a RET transgenic mouse model Cancer Res. 63 4777 4780
15. T Watanabe M Ichihara M Hashimoto 2000 Characterization of gene expression induced by RET with MEN2A or MEN2B mutation Am. J. Pathol. 161 249 256
16. S Jain MA Watson MK DeBenedetti 2004 Expression profiles provide insights into early malignant potential and skeletal abnormalities in multiple endocrine neoplasia type 2B syndrome tumors Cancer Res. 64 3907 3913
17. C Eng LM Mulligan CS Healey 1996 Heterogeneous mutation of the RET proto-oncogene in subpopulations of medullary thyroid carcinoma Cancer Res. 56 2167 2170
18. K Emoto Y Yamada H Sawada 2001 Annexin II overexpression correlates with stromal tenascin C overexpression: a prognostic marker in colorectal carcinoma Cancer 92 1419 1426
19. K Emoto H Sawada Y Yamada 2001 Annexin II overexpression is correlated with poor prognosis in human gastric carcinoma Anticancer Res. 21 1339 1345
20. H Stenmark VM Olkkonen 2001 The Rab GTPase family Genome Biol. 2. REVIEWS3007
21. M Zerial H McBride 2001 Rab proteins as membrane organizers Nat. Rev. Mol. Cell. Biol. 2 107 117
22. N Zobiack U Rescher C Ludwig 2003 The annexin 2/S100A10 complex controls the distribution of transferrin receptor-containing recycling endosomes Mol. Biol. Cell. 14 4896 4908
23. FE May BR Westley 1997 Trefoil proteins: their role in normal and malignant cells J. Pathol. 183 4 7
24. M Marikovsky N Nevo E Vadai 2002 Cu/Zn superoxide dismutase plays a role in angiogenesis Int. J. Cancer. 14 4876 4908
25. HC Ha A Thiagalingam BD Nelkin 2000 Reactive oxygen species are critical for the growth and differentiation of medullary thyroid carcinoma cells Clin. Cancer Res. 6 3783 3787
26. LR Cavalli BC Liang 1998 Mutagenesis, tumorigenicity, and apoptosis: are the mitochondria involved? Mutat. Res. 398 19 26
27. MS Fliss H Usadel OL Caballero 2000 Facile detection of mitochondrial DNA mutations in tumors and bodily fluids Science 287 2017 2019
28. VW Liu HH Shi AN Cheung 2001 High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas Cancer Res. 61 5998 6001
29. JZ Chen N Gokden GF Greene 2002 Extensive somatic mitochondrial mutations in primary prostate cancer using laser capture microdissection Cancer Res 62 6470 6474
30. T van Biesen LM Luttrell BE Hawes 1996 Mitogenic signaling via G protein-coupled receptors Endocr Rev. 17 698 714
31. EA Balcueva Q Wang H Hughes 2000 Human G protein gamma(11) and gamma(14) subtypes define a new functional subclass Exp. Cell. Res. 257 310 319
32. BM Putzer M Drosten 2004 The RET proto-oncogene: a potential target for molecular cancer therapy Trends Mol. Med. 10 351 357